Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorComputer and Technology
Phone571-389-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$627.06 million
Profitability
Miscellaneous
Employees2,600
Next Earnings Date5/8/2019 (Estimated)
OptionableOptionable
Evolent Health (NYSE:EVH) Frequently Asked Questions
What is Evolent Health's stock symbol?
Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."
How were Evolent Health's earnings last quarter?
Evolent Health Inc (NYSE:EVH) posted its quarterly earnings data on Tuesday, February, 26th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.02. The technology company earned $193.10 million during the quarter, compared to analyst estimates of $188.66 million. Evolent Health had a negative net margin of 8.40% and a negative return on equity of 2.39%. Evolent Health's revenue for the quarter was up 69.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.04) earnings per share. View Evolent Health's Earnings History.
When is Evolent Health's next earnings date?
What guidance has Evolent Health issued on next quarter's earnings?
Evolent Health updated its first quarter 2019 earnings guidance on Tuesday, February, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $188-197 million, compared to the consensus revenue estimate of $205.02 million.Evolent Health also updated its FY 2019 guidance to EPS.
What price target have analysts set for EVH?
11 brokerages have issued 1 year target prices for Evolent Health's stock. Their forecasts range from $20.00 to $35.00. On average, they anticipate Evolent Health's stock price to reach $27.15 in the next twelve months. This suggests a possible upside of 115.0% from the stock's current price. View Analyst Price Targets for Evolent Health.
What is the consensus analysts' recommendation for Evolent Health?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.
Has Evolent Health been receiving favorable news coverage?
Media stories about EVH stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Evolent Health earned a coverage optimism score of 1.4 on InfoTrie's scale. They also gave news stories about the technology company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
Who are some of Evolent Health's key competitors?
Some companies that are related to Evolent Health include Jabil (JBL), Commscope (COMM), LogMeIn (LOGM), J2 Global (JCOM), SINA (SINA), LiveRamp (RAMP), United States Cellular (USM), Lumentum (LITE), KINGDEE INTL SO/ADR (KGDEY), SPECTRIS PLC/ADR (SEPJY), 2U (TWOU), Cyberark Software (CYBR), Dainippon Screen (DINRF), ALPS ELEC LTD/ADR (APELY) and ACI Worldwide (ACIW).
What other stocks do shareholders of Evolent Health own?
Who are Evolent Health's key executives?
Evolent Health's management team includes the folowing people:
- Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
- Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
- Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
- Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
- Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)
When did Evolent Health IPO?
(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.
Who are Evolent Health's major shareholders?
Evolent Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (6.55%), BlackRock Inc. (5.68%), Riverbridge Partners LLC (4.62%), Dimensional Fund Advisors LP (3.94%), Eagle Asset Management Inc. (2.86%) and Standard Life Aberdeen plc (2.56%). Company insiders that own Evolent Health stock include Board Co Advisory, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Institutional Ownership Trends for Evolent Health.
Which major investors are selling Evolent Health stock?
EVH stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Bank of New York Mellon Corp, Monarch Partners Asset Management LLC, Columbus Circle Investors, Granite Investment Partners LLC, Oak Ridge Investments LLC, CWM LLC and Tekla Capital Management LLC. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Lydia Stone, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Insider Buying and Selling for Evolent Health.
Which major investors are buying Evolent Health stock?
EVH stock was purchased by a variety of institutional investors in the last quarter, including American Century Companies Inc., D. E. Shaw & Co. Inc., Riverbridge Partners LLC, Norges Bank, Standard Life Aberdeen plc, Nicholas Company Inc., Westfield Capital Management Co. LP and Elk Creek Partners LLC. View Insider Buying and Selling for Evolent Health.
How do I buy shares of Evolent Health?
Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Evolent Health's stock price today?
One share of EVH stock can currently be purchased for approximately $12.63.
How big of a company is Evolent Health?
Evolent Health has a market capitalization of $1.04 billion and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe.
What is Evolent Health's official website?
How can I contact Evolent Health?
Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.
MarketBeat Community Rating for Evolent Health (NYSE EVH)
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
